To understand the mechanism underlying the tumor-specific anti-metastasis property of the PVAX, the effector memory (CD11b+CD8+CD44+CD62L−) T cells in the spleen, LNs and bone marrow were examined by using flow cytometric measurement on the same day as the i.v. infusion of 4T1 cells. This evidence concerns the gene SELL and neoplasm.